Benitec Biopharma Inc. - Common Stock (BNTC)

Historical Holders from Q3 2023 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
BNTC on Nasdaq
Shares outstanding
33,862,222
Price per share
$13.48
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
23,155,290
Total reported value
$324,725,424
% of total 13F portfolios
0%
Share change
+468,856
Value change
+$6,865,160
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
54
Price from insider filings
$13.44
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Benitec Biopharma Inc. - Common Stock (BNTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 44% -12% $249,200,088 +$30,000,153 17,761,945 +14% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Nov 2025
FRANKLIN RESOURCES INC 15% -8.8% $58,140,839 -$3,803,435 4,144,037 -6.1% Franklin Resources, Inc. 30 Sep 2025
JANUS HENDERSON GROUP PLC 10% -12% $44,484,293 -$292,158,468 3,382,836 -87% JANUS HENDERSON GROUP PLC 28 Nov 2025
RA CAPITAL MANAGEMENT, L.P. 5.5% $24,327,500 1,850,000 RA Capital Management, L.P. 07 Nov 2025
HBM Healthcare Investments (Cayman) Ltd. 4.5% $14,156,282 1,041,669 HBM Healthcare Investments (Cayman) Ltd. 31 Dec 2024
Nantahala Capital Management, LLC 4.4% -53% $14,111,462 1,038,371 0% Nantahala Capital Management, LLC 31 Mar 2025
As of 30 Sep 2025, Benitec Biopharma Inc. - Common Stock (BNTC) has 54 institutional shareholders filing 13F forms. They hold 23,155,290 shares. of 33,862,222 outstanding shares (68%) .

Top 25 institutional shareholders own 68% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
SUVRETTA CAPITAL MANAGEMENT, LLC 29% 9,876,506 0% 4.2% $138,567,379
JANUS HENDERSON GROUP PLC 8.6% 2,911,688 +0.31% 0.02% $40,705,398
FRANKLIN RESOURCES INC 7.6% 2,589,633 -4.1% 0.01% $36,332,551
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.8% 1,972,524 0% 0.04% $27,674,512
VANGUARD GROUP INC 2.9% 992,114 +2.4% 0% $13,919,360
BlackRock, Inc. 2.8% 945,515 +32% 0% $13,265,576
Nantahala Capital Management, LLC 2.5% 838,095 0% 0.73% $11,758,473
INFINITUM ASSET MANAGEMENT, LLC 1.5% 500,000 0% 1.3% $7,015,000
GEODE CAPITAL MANAGEMENT, LLC 1.3% 438,505 +5.6% 0% $6,153,972
SILVERARC CAPITAL MANAGEMENT, LLC 0.82% 276,267 +9.1% 0.56% $3,876,026
Schonfeld Strategic Advisors LLC 0.77% 260,419 +0% 0.03% $3,653,678
STATE STREET CORP 0.64% 218,398 +36% 0% $3,064,124
GOLDMAN SACHS GROUP INC 0.57% 194,363 +826% 0% $2,726,913
AWM Investment Company, Inc. 0.54% 182,977 +33% 0.24% $2,567,167
AMERIPRISE FINANCIAL INC 0.46% 154,414 +40% 0% $2,166,428
NORTHERN TRUST CORP 0.39% 130,615 +3.4% 0% $1,832,528
UBS Group AG 0.3% 99,941 +459% 0% $1,402,172
Simplify Asset Management Inc. 0.23% 78,725 +14% 0.02% $1,104,512
ExodusPoint Capital Management, LP 0.23% 77,912 +2% 0.02% $1,093,105
MYDA Advisors LLC 0.21% 70,000 +13% 0.3% $982,100
Lion Point Capital, LP 0.18% 62,000 0% 4.9% $869,860
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.13% 45,274 0% 0% $635,194
Longaeva Partners L.P. 0.11% 37,537 -28% 0.11% $526,644
Bank of New York Mellon Corp 0.1% 34,001 +6.4% 0% $477,034
BARCLAYS PLC 0.06% 21,283 -21% 0% $298,600

Institutional Holders of Benitec Biopharma Inc. - Common Stock (BNTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 14,957 $201,586 +$110,987 1,347.7% 2
2025 Q3 23,155,290 $324,725,424 +$6,865,160 1,403% 54
2025 Q2 22,685,530 $265,306,276 +$16,737,178 1,170% 56
2025 Q1 21,243,183 $277,395,506 +$28,289,371 1,301% 37
2024 Q4 18,997,897 $240,166,135 +$64,576,294 1,263% 30
2024 Q3 13,715,023 $126,792,177 +$73,385,856 919% 25
2024 Q2 5,729,459 $39,940,820 +$31,087,038 699% 18
2024 Q1 1,270,837 $6,576,960 +$379,920 524.99% 13
2023 Q4 1,197,615 $3,880,452 -$214,565 323.01% 13
2023 Q3 1,267,947 $3,838,114 +$3,838,114 302% 11